All News & Stories
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
Cancer Care Close to Home: New Hampshire’s Only NCI-Designated Comprehensive Cancer Center Expands Cancer Services in Southern New Hampshire
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center will open two new specialty clinics, NeuroOncology and Gynecologic Oncology, at their Dartmouth-Hitchcock location at the Catholic Medical Center’s Notre Dame Pavilion in Manchester.
Read answers to frequently asked questions related to the safety and efficacy of the COVID-19 vaccine for patients undergoing treatment for cancer.
Dr. Lewis elected for prestigious fellowship for his substantial contributions, demonstrated distinction, and peer recognition in clinical pharmacology and therapeutics.
Bill and Sue Conaty pledge $5.25 million in support of Dartmouth-Hitchcock Medical Center’s new Patient Pavilion
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.